Year: 2024
Type: article
Study design: Observational Study
Abstract: BACKGROUND: The World Health Organization has declared the end of the coronavirus disease 2019 (COVID-19) public health emergency. However, this did not indicate the end of COVID-19. Several months after the infection, numerous patients complain of respiratory or nonspecific symptoms; this condition is called long COVID. Even patients with mild COVID-19 can experience long COVID, thus the burden of long COVID remains considerable. Therefore, we conducted this study to comprehensively analyze the effects of long COVID using multi-faceted assessments. MATERIALS AND METHODS: We conducted a prospective cohort study involving patients diagnosed with COVID-19 between February 2020 and September 2021 in six tertiary hospitals in Korea. Patients were followed up at 1, 3, 6, 12, 18, and 24 months after discharge. Long COVID was defined as the persistence of three or more COVID-19-related symptoms. The primary outcome of this study was the prevalence of long COVID after the period of COVID-19. RESULTS: =0.04) showed a significant association with long COVID after 12-18 months in a multivariable logistic regression analysis. CONCLUSION: Many patients still showed long COVID after 18 months post SARS-CoV-2 infection. When managing these patients, the assessment of multiple aspects is necessary.
Source: Infection and Chemotherapy
DOI: 10.3947/ic.2024.0090
Institutions: Inha University, Yonsei University, Inha University Hospital, Yonsei University Health System, Soonchunhyang University, Soonchunhyang University Hospital Seoul, Chungbuk National University, Chungbuk National University Hospital, Korea University Ansan Hospital, Seoul National University, Seoul National University Bundang Hospital, Samsung Medical Center, Sungkyunkwan University, Seoul Medical Center
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $200
Awards: G1175871383, G6374563342
OpenAlex ID: W4405091196